The Journal of Rheumatology: 74

March 01, 2005; Volume 74,

Mechanism of Action of Tumor Necrosis Factor Antagonists

You have access
Mechanism of action of tumor necrosis factor antagonists. Proceedings of the Canadian expert roundtable meeting, Banff, Canada, November 28-30, 2003.
The Journal of Rheumatology Supplement March 1 2005, 74 1-47;
You have access
Differentiating the efficacy of tumor necrosis factor inhibitors.
Boulos Haraoui

The Journal of Rheumatology Supplement March 1 2005, 74 3-7;
You have access
Safety of biologic therapies--an update.
Edward C Keystone

The Journal of Rheumatology Supplement March 1 2005, 74 8-12;
You have access
Clinical pharmacokinetics of tumor necrosis factor antagonists.
Ivan Nestorov

The Journal of Rheumatology Supplement March 1 2005, 74 13-18;
You have access
Apoptosis in the regulation of immune responses.
Michael J Pinkoski and Douglas R Green

The Journal of Rheumatology Supplement March 1 2005, 74 19-25;
You have access
Infliximab induced T lymphocyte apoptosis in Crohn's disease.
Jan van den Brande, Daan W Hommes and Maikel P Peppelenbosch

The Journal of Rheumatology Supplement March 1 2005, 74 26-30;
You have access
Effects of infliximab treatment on rheumatoid synovial tissue.
Paul P Tak

The Journal of Rheumatology Supplement March 1 2005, 74 31-34;
You have access
Why does tumor necrosis factor targeted therapy reactivate tuberculosis?
Stefan Ehlers

The Journal of Rheumatology Supplement March 1 2005, 74 35-39;
You have access
Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment.
Charles A Dinarello

The Journal of Rheumatology Supplement March 1 2005, 74 40-47;

Main menu

User menu

Search

Table of Contents

Mechanism of Action of Tumor Necrosis Factor Antagonists

In this issue

Content

Resources

Subscribers

More